Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
0.59
↓ 99% below average
Average (9y)
72.77
Historical baseline
Range
High:378.12
Low:0.59
CAGR
-34.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 0.59 | -51.4% |
| 2023 | 1.22 | -58.2% |
| 2022 | 2.91 | -21.0% |
| 2021 | 3.69 | +41.4% |
| 2020 | 2.61 | -26.0% |
| 2019 | 3.52 | -99.1% |
| 2018 | 378.12 | +25.8% |
| 2017 | 300.50 | +4741.9% |
| 2016 | 6.21 | -78.1% |
| 2015 | 28.37 | - |